SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Sponsored
WHITE PAPER: Validated devices for easy self-collection and stabilization of vaginal microbiome samples
The vaginal microbiome plays a critical role in women’s health, from infection resistance to fertility, yet it continues to remain underexplored. With DNA Genotek™’s OMNIgene™•VAGINAL collection kit, researchers and innovators are empowered to collect stablized samples with precision to support women’s healthcare research and development of healthcare for women.
September 8, 2025
 · 
1 min read
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Neuroscience
Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy
KER-0193 is a modulator of ion channels connected to autism spectrum disorder. The FDA bestowed orphan drug and rare pediatric drug designations on the candidate earlier this year.
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative collage image young man builder architect engineer occupation lungs healthcare illness disease drawing background.
Lung cancer
Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd
According to analysts, the new data could present a path to accelerated approval for ifinatamab deruxtecan, a product of Merck and Daiichi Sankyo’s troubled ADC partnership.
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Courtesy of diegograndi/Getty Images
GLP-1
WHO Adds GLP-1s to List of Essential Medicines
The World Health Organization’s Essential Medicines list guides high-level procurement and coverage decisions for over 150 countries.
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
There is no place for the red man in the group. Social isolation. Exclusion, discrimination.
FDA
FDA Expert Panels Lack Balance in Pursuit of ‘Gold Standard Science’
New FDA expert panels, such as recent meetings on SSRI use during pregnancy and on hormone replacement therapy during menopause, are drawing criticism for being one-sided. One leader says such panels are designed to reach a specific conclusion.
September 8, 2025
 · 
6 min read
 · 
Ben Hargreaves
Bright streaks of light of a spinning carousel in motion, capturing the energy and excitement of a night at the fairground
FDA
5 Companies Caught on a Carousel of FDA Confusion
Amid an unprecedented turnover in leadership at the FDA and mass layoffs of staff, communication has crumbled and uncertainty runs rampant, leaving small and medium biopharma companies without a clear path forward for their therapies.
September 8, 2025
 · 
8 min read
 · 
Heather McKenzie
graphic pattern with the tablet. topic of drugs. pill with girl and space inside. relax
Psychedelics
With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’
Rick Doblin, the founder of the Multidisciplinary Association for Psychedelic Studies, which founded Lykos, bemoaned a “moving of the goal posts” in Lykos’ rejection but looked for positives in the newly released complete response letter.
September 5, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Robert F Kennedy Jr speaking in front of the Senate finance committee
Government
Senate Hearing Devolves Into Theater as Kennedy Accused of Breaking Vaccine Promises
Robert F. Kennedy Jr. repeated a series of anti-vaccine talking points during his appearance in front of the Senate finance committee on Thursday, as Democratic and Republican senators alike hammered the Health Secretary on recent COVID-19 vaccine restrictions and his views on Operation Warp Speed.
September 5, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
Susan Monarez speaking to a senator at her confirmation hearing as CDC director
Government
Monarez Blasts Partisan Public Health Policy at CDC Under RFK Jr.
Ousted CDC Director Susan Monarez claimed in an op-ed published in The Wall Street Journal Thursday that she was fired for refusing to rubber-stamp COVID-19 recommendations to be made by an advisory panel that has expressed “antivaccine rhetoric.”
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS